Defections Plague MCC's Superconductivity Venture

Two years ago officials at NCR Corp. scanned the high-technology horizon and saw the discovery of high-temperature superconductors as a once-rn-a-lifetime opportunity for the computer giant. But the Dayton, Ohio, company had a problem: it had never researched superconductivity, and it didn’t know the best way to enter this fast-moving field. To overcome its ignorance, NCR shelled out $100,000. to become a founding member of an industrial consortium on superconductivity being formed by the

| 5 min read

Register for free to listen to this article
Listen with Speechify
0:00
5:00
Share

Two years ago officials at NCR Corp. scanned the high-technology horizon and saw the discovery of high-temperature superconductors as a once-rn-a-lifetime opportunity for the computer giant. But the Dayton, Ohio, company had a problem: it had never researched superconductivity, and it didn’t know the best way to enter this fast-moving field. To overcome its ignorance, NCR shelled out $100,000. to become a founding member of an industrial consortium on superconductivity being formed by the Microelectronics and Computer Technology Corp., itself a 19-member industrial consortium dedicated to cutting-edge computer and electronic research.

Now, a little more than a year later, NCR officialsadmit they were a bit hasty jumping on the superconductivity bandwagon. The MCC program is a shadow of its former self: NCR and five other original members have already pulled out, and others are reportedly on the verge of withdrawing (see table, page 13). The decision of many to leave ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

  • Christopher Anderson

    This person does not yet have a bio.

Published In

Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo
Characterizing Immune Memory to COVID-19 Vaccination

Characterizing Immune Memory to COVID-19 Vaccination

10X Genomics
Optimize PCR assays with true linear temperature gradients

Applied Biosystems™ VeriFlex™ System: True Temperature Control for PCR Protocols

Thermo Fisher Logo

Products

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours

iStock

Agilent BioTek Cytation C10 Confocal Imaging Reader

agilent technologies logo